Glaucoma Specialty Sales Rep - Omaha
Location: Omaha Nebraska
Description: Novartis is at present recruited Glaucoma Specialty Sales Rep - Omaha right now, this position will be placed in Nebraska. Detailed specification about this position opportunity kindly see the descriptions. This is a universal job description meant to capture some of the primary duties of this role that are common across functions or divisions. It is not intended to represent all of t! he specific responsibilities of your position. The incumbent will be responsible for managing the business of an assigned sales territory and achieving product specific quota attainment through POA execution of sales product interactions while providing service for all Ophthalmic glaucoma products as well as allergy and tears; managing a territory and calling on ophthalmologists in certain markets, hospitals, surgery centers and retail pharmacies, ensuring adequate product distribution; interfacing with customers, Alcon sales management, and marketing and customer service departments. Sales calls may overlap with calls made by other Ophthalmic reps for other products, such as allergy, anti-infective, etc.
Functions independently in sales territory, with periodic direction from sales management. Makes all day-to-day decisions on sales calls, territory management and administration, handling customers service issues and opportunities, implementing marketing plans. Ad! ditional responsibilities may include: Managed care support an! d formulary implementation. Refer to Annual performance target setting Minimum requirements Bachelors degree with some advanced business/science courses Fluent in English Two years outside sales experience.
Promotion from 15E to 16E after 6 mo of Alcon experience
- .
If you were eligible to this position, please email us your resume, with salary requirements and a resume to Novartis.
If you interested on this position just click on the Apply button, you will be redirected to the official website
This position starts available on: Wed, 21 Aug 2013 19:59:15 GMT